Detalles de la búsqueda
1.
Neuroendocrine Response to Exogenous Ghrelin Administration, Combined With Alcohol, in Heavy-Drinking Individuals: Findings From a Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study.
Int J Neuropsychopharmacol
; 24(6): 464-476, 2021 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33560411
2.
The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study.
Mol Psychiatry
; 25(2): 461-475, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29728704
3.
Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.
Drug Metab Rev
; 49(2): 197-211, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28303724
4.
A Population Pharmacokinetic Analysis of PF-5190457, a Novel Ghrelin Receptor Inverse Agonist in Healthy Volunteers and in Heavy Alcohol Drinkers.
Clin Pharmacokinet
; 60(4): 471-484, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33155163
5.
A systems pharmacology model for gene therapy in sickle cell disease.
CPT Pharmacometrics Syst Pharmacol
; 10(7): 696-708, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34139105
6.
Endocrine effects of the novel ghrelin receptor inverse agonist PF-5190457: Results from a placebo-controlled human laboratory alcohol co-administration study in heavy drinkers.
Neuropharmacology
; 170: 107788, 2020 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31557492
Resultados
1 -
6
de 6
1
Próxima >
>>